Behcet's disease (BD) is a chronic systemic inflammatory vasculitis of unknown etiology
characterized by recurrent episodes of oral aphthous ulcers, genital ulcers, skin lesions …

Behçet's disease (BD) is a chronic, relapsing, inflammatory multisystem disease of unknown
etiology. Oral ulcers, genital ulcers, cutaneous lesions, and ocular and articular involvement …

Topic To provide recommendations for the use of anti-tumor necrosis factor α (TNF-α)
biologic agents in patients with ocular inflammatory disorders. Clinical Relevance Ocular …

Behçet's disease, also known as the Silk Road Disease, is a rare systemic vasculitis
disorder of unknown etiology. Recurrent attacks of acute inflammation characterize Behçet's …

Objectives: To develop evidence-based European League Against Rheumatism (EULAR)
recommendations for the management of Behçet disease (BD) supplemented where …

PURPOSE: To determine the efficacy and safety of different doses of secukinumab, a fully
human monoclonal antibody for targeted interleukin-17A blockade, in patients with …

Objective To report the efficacy and safety of anti-TNF agents in patients with severe and/or
refractory manifestations of Behçet's disease (BD). Methods We performed a multicenter …

Behçet's disease (BD) is a systemic vasculitis disorder of unknown etiology, characterized
by relapsing episodes of oral aphthous ulcers, genital ulcers, skin lesions and ocular …

Behçet's disease (BD) is an idiopathic, chronic, relapsing, multi-systemic vasculitis
characterized by recurrent oral and genital aphthous ulcers, ocular disease and skin lesions …

OBJECTIVE:: Off-label use of anti-tumor necrosis factor (TNF) agents for Behçet's disease
(BD) is increasing. We evaluated published data on their efficacy and safety for patients with …